TY - JOUR
T1 - One-carbon metabolism and schizophrenia
T2 - current challenges and future directions
AU - Krebs, M. O.
AU - Bellon, Alfredo
AU - Mainguy, Gaell
AU - Jay, T. M.
AU - Frieling, Helge
N1 - Funding Information:
This study was supported by post-doctoral grants from the Fondation de la Recherche Medicale, France for G.M. and from INSERM, France for A.B. A.B. also receives support from CONACYT scholarship #74641 and the Young Minds in Psychiatry Award given by the American Psychiatric Association.
Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 2009/12
Y1 - 2009/12
N2 - Schizophrenia is a heterogeneous disease generally considered to result from a combination of heritable and environmental factors. Although its pathophysiology has not been fully determined, biological studies support the involvement of several possible components including altered DNA methylation, abnormal glutamatergic transmission, altered mitochondrial function, folate deficiency and high maternal homocysteine levels. Although these factors have been explored separately, they all involve one-carbon (C1) metabolism. Furthermore, C1 metabolism is well positioned to integrate gene-environment interactions by influencing epigenetic regulation. Here, we discuss the potential roles of C1 metabolism in the pathophysiology of schizophrenia. Understanding the contribution of these mechanisms could yield new therapeutic approaches aiming to counteract disease onset or progression.
AB - Schizophrenia is a heterogeneous disease generally considered to result from a combination of heritable and environmental factors. Although its pathophysiology has not been fully determined, biological studies support the involvement of several possible components including altered DNA methylation, abnormal glutamatergic transmission, altered mitochondrial function, folate deficiency and high maternal homocysteine levels. Although these factors have been explored separately, they all involve one-carbon (C1) metabolism. Furthermore, C1 metabolism is well positioned to integrate gene-environment interactions by influencing epigenetic regulation. Here, we discuss the potential roles of C1 metabolism in the pathophysiology of schizophrenia. Understanding the contribution of these mechanisms could yield new therapeutic approaches aiming to counteract disease onset or progression.
UR - http://www.scopus.com/inward/record.url?scp=70949085092&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70949085092&partnerID=8YFLogxK
U2 - 10.1016/j.molmed.2009.10.001
DO - 10.1016/j.molmed.2009.10.001
M3 - Article
C2 - 19896901
AN - SCOPUS:70949085092
SN - 1471-4914
VL - 15
SP - 562
EP - 570
JO - Trends in Molecular Medicine
JF - Trends in Molecular Medicine
IS - 12
ER -